SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 409 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,935,478 | +3.6% | 164,457 | -2.2% | 0.02% | 0.0% |
| Q2 2023 | $19,251,499 | -16.3% | 168,106 | +0.8% | 0.02% | -15.0% |
| Q1 2023 | $22,996,384 | -7.7% | 166,846 | -13.2% | 0.02% | -4.8% |
| Q4 2022 | $24,906,701 | +17.8% | 192,211 | +0.5% | 0.02% | +10.5% |
| Q3 2022 | $21,142,000 | +67.4% | 191,264 | +13.5% | 0.02% | +58.3% |
| Q2 2022 | $12,631,000 | -6.5% | 168,498 | -2.5% | 0.01% | +20.0% |
| Q1 2022 | $13,503,000 | -15.8% | 172,853 | -3.0% | 0.01% | -9.1% |
| Q4 2021 | $16,039,000 | +2.4% | 178,111 | +5.2% | 0.01% | -8.3% |
| Q3 2021 | $15,659,000 | +30.6% | 169,327 | +9.8% | 0.01% | +33.3% |
| Q2 2021 | $11,987,000 | -4.9% | 154,194 | -8.8% | 0.01% | -10.0% |
| Q1 2021 | $12,608,000 | -59.3% | 169,164 | -6.9% | 0.01% | -58.3% |
| Q4 2020 | $30,987,000 | +29.0% | 181,754 | +6.3% | 0.02% | +14.3% |
| Q3 2020 | $24,016,000 | -1.2% | 171,019 | +12.8% | 0.02% | -12.5% |
| Q2 2020 | $24,319,000 | +71.8% | 151,669 | +4.8% | 0.02% | +41.2% |
| Q1 2020 | $14,155,000 | -43.7% | 144,700 | -25.8% | 0.02% | -26.1% |
| Q4 2019 | $25,160,000 | +156.8% | 194,977 | +49.9% | 0.02% | +130.0% |
| Q3 2019 | $9,799,000 | -31.9% | 130,100 | +37.4% | 0.01% | -41.2% |
| Q2 2019 | $14,390,000 | -0.6% | 94,700 | -22.0% | 0.02% | -5.6% |
| Q1 2019 | $14,472,000 | +5.9% | 121,420 | -3.0% | 0.02% | -5.3% |
| Q4 2018 | $13,660,000 | -34.9% | 125,176 | -3.7% | 0.02% | -29.6% |
| Q3 2018 | $20,986,000 | +24.8% | 129,938 | +2.1% | 0.03% | +17.4% |
| Q2 2018 | $16,817,000 | +55.9% | 127,228 | -12.6% | 0.02% | +53.3% |
| Q1 2018 | $10,788,000 | +32.2% | 145,604 | -0.7% | 0.02% | +36.4% |
| Q4 2017 | $8,162,000 | +25.9% | 146,700 | +2.7% | 0.01% | +10.0% |
| Q3 2017 | $6,482,000 | +36.2% | 142,900 | +1.2% | 0.01% | +25.0% |
| Q2 2017 | $4,760,000 | +16.4% | 141,200 | +2.2% | 0.01% | +14.3% |
| Q1 2017 | $4,088,000 | +3.4% | 138,100 | -4.2% | 0.01% | 0.0% |
| Q4 2016 | $3,953,000 | -57.5% | 144,100 | -4.8% | 0.01% | -53.3% |
| Q3 2016 | $9,298,000 | +201.3% | 151,400 | -6.4% | 0.02% | +200.0% |
| Q2 2016 | $3,086,000 | -5.3% | 161,800 | -3.1% | 0.01% | 0.0% |
| Q1 2016 | $3,258,000 | -52.3% | 166,900 | -5.8% | 0.01% | -54.5% |
| Q4 2015 | $6,833,000 | +20.2% | 177,100 | 0.0% | 0.01% | +10.0% |
| Q3 2015 | $5,687,000 | +5.5% | 177,100 | 0.0% | 0.01% | +25.0% |
| Q2 2015 | $5,389,000 | +147.0% | 177,100 | 0.0% | 0.01% | +166.7% |
| Q1 2015 | $2,182,000 | 0.0% | 177,100 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $2,182,000 | -3.2% | 177,100 | +65.8% | 0.00% | 0.0% |
| Q3 2014 | $2,253,000 | -29.2% | 106,800 | 0.0% | 0.00% | -25.0% |
| Q2 2014 | $3,182,000 | +17.7% | 106,800 | -1.7% | 0.00% | 0.0% |
| Q1 2014 | $2,703,000 | +24.4% | 108,600 | 0.0% | 0.00% | +33.3% |
| Q4 2013 | $2,172,000 | -58.2% | 108,600 | -1.3% | 0.00% | -70.0% |
| Q3 2013 | $5,195,000 | +42.6% | 110,000 | +14.9% | 0.01% | +42.9% |
| Q2 2013 | $3,644,000 | – | 95,766 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonic Fund II, L.P. | 112,689 | $14,541,000 | 14.93% |
| Casdin Capital, LLC | 670,000 | $86,457,000 | 7.95% |
| Logos Global Management LP | 226,002 | $29,163,000 | 7.19% |
| Avoro Capital Advisors LLC | 1,760,000 | $227,110,000 | 6.67% |
| Camber Capital Management LP | 600,000 | $77,424,000 | 3.94% |
| STANSBERRY ASSET MANAGEMENT, LLC | 71,133 | $9,179,000 | 3.74% |
| Eventide Asset Management | 996,000 | $128,524,000 | 3.62% |
| CADIAN CAPITAL MANAGEMENT, LP | 550,000 | $70,972,000 | 3.14% |
| RTW INVESTMENTS, LP | 605,762 | $78,168,000 | 2.95% |
| Consonance Capital Management LP | 356,145 | $45,957,000 | 2.80% |